Constant S Lead Drug Candidatetxa127Is A Pharmaceutical Formulation Of The Natural Human Peptideangiotensin1 7 Ang1 7 Ang1 7 The Active Ingredient In Constant S Producttxa127Has Been Shown To Have Multiple Biologic Effects Stimulating Endothelial Progenitor Cells Stimulating Muscle Satellite Cells Stimulating Oligodendrocyte Progenitor Cells Reducing Oxidative Stress And Ros Restoring The Integrity Of Epithelial And Endothelial Surfaces Reducing Inflammation By Reversing The Increased Permeability Of The Blood Vessels Caused By The Virusthereby Preventing Movement Of Inflammatory Cells Into Tissue Leading To Thecytokine Storm Reducing Apoptosis Inhibiting Coagulopathyand Reducing Fibrosis Through Down Regulation Of The Tgf Beta Pathway Ang1 7Has Been Shown To Have Positive Outcomes In A Number Of Animal Models Of Strokeheart Diseaseand Muscle Dystrophiesin Additionin Several Disease Models It Has Become Clear That Blocking The Effect Of Ang1 7Is Detrimental
No conferences found for this company.
| Company Name | Constant Therapeutics Llc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.